Research analysts at StockNews.com assumed coverage on shares of Oxbridge Re (NASDAQ:OXBR – Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the insurance provider’s stock.
Oxbridge Re Stock Up 2.2 %
Shares of NASDAQ:OXBR opened at $2.35 on Wednesday. Oxbridge Re has a fifty-two week low of $0.87 and a fifty-two week high of $3.72. The firm’s 50 day moving average price is $2.52 and its 200 day moving average price is $1.92. The stock has a market cap of $14.19 million, a price-to-earnings ratio of -1.26 and a beta of 0.94.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The insurance provider reported ($0.14) earnings per share for the quarter. The firm had revenue of $0.04 million for the quarter.
Insider Transactions at Oxbridge Re
Hedge Funds Weigh In On Oxbridge Re
An institutional investor recently raised its position in Oxbridge Re stock. Henrickson Nauta Wealth Advisors Inc. raised its holdings in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 50.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,000 shares of the insurance provider’s stock after purchasing an additional 5,000 shares during the quarter. Henrickson Nauta Wealth Advisors Inc. owned about 0.25% of Oxbridge Re worth $36,000 as of its most recent filing with the SEC. 5.64% of the stock is currently owned by institutional investors and hedge funds.
About Oxbridge Re
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Investing In Automotive Stocks
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What is an Earnings Surprise?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- The Most Important Warren Buffett Stock for Investors: His Own
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.